Florida
October 1, 2026
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
April 10, 2026
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community